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Chemical crosslinking of proteins combined with mass spectrometric analysis of the tryptic
digest of the products shows considerable promise as a tool for interrogating structure and
geometry of proteins and protein complexes. An impediment to the use of this tool has been
the difficulty of distinguishing crosslinked peptide pairs from non-crosslinked peptides, and
from the products of side reactions. We describe the use of a commercially available
biotinylated crosslinking reagent, sulfo-SBED, that allows affinity-based enrichment of
crosslinked species. An intramolecular crosslink is prepared using the peptide neurotensin as
a model system. Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass
spectra show the predicted crosslinking product, as well as several side products. Finally, we
describe the optimized enrichment of biotinylated species, and reduction of non-specific
binding, for a batch-mode affinity separation based on immobilized monomeric
avidin. (J Am Soc Mass Spectrom 2004, 15, 832–839) © 2004 American Society for Mass
SpectrometryChemical crosslinking is an established tool forstudying protein structure and protein–proteininteractions [1–4]. Crosslinking reagents intro-
duce new covalent bonds into the three-dimensional
(3D) structure of a protein or protein complex. The
locations of these new bonds, along with the length and
reactivity of the crosslinking reagent, provide low-
resolution information on spatial relationships in the
original 3D structure of the protein or protein complex
[2, 5–7]. However, determining the locations of the
bonds introduced by the crosslinking reagent has
proven to be a fairly difficult analytical task.
The recent growth of mass spectrometry (MS) capa-
bilities for protein and peptide analysis have led to
exploration of the utility of MS for elucidating locations
of new covalent bonds introduced into proteins by
chemical crosslinking reagents [1, 5, 8–10]. One strategy
is to introduce crosslinks into a protein, digest the
protein, and obtain peptide masses by MS, or peptide
fragmentation patterns by tandem MS. Both non-
crosslinked peptides and crosslinked pairs of peptides
will be represented in the mass spectrum; the latter
could in principle be recognized by comparison with
the mass spectrum from a digested, but non-
crosslinked, sample of the protein.
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facile implementation of this strategy. Yields of
crosslinking reactions may be low because of the neces-
sity to avoid excessive crosslinking, which could distort
the structures of the proteins under study. Because of
this need to keep the number of crosslink events low
(on the order of one per protein molecule [5]), large
numbers of peptides in the subsequent enzymatic di-
gest will not contain a crosslink. These peptides, which
are not of primary utility for analysis of crosslinking
products, constitute an interference to the detection of
crosslinked peptide pairs. Additionally, side reactions
to the crosslinking introduce non-informative peptides.
For instance, only one end of a bifunctional crosslinking
reagent might attach to the protein, while the other end
undergoes hydrolysis, to yield an adduct on the protein
(“surface labeling” or “single-ended” crosslinking).
In addition to these difficulties inherent to the mass
spectrometric measurement of crosslinked peptide
pairs, further complications arise in extracting informa-
tion on crosslinked peptide pairs from mass spectro-
metry data. A polypeptide with n enzymatic cleavage
sites has possible cleavage products if incom-
plete cleavage is considered. If f is the fraction of these
cleavage products containing a potential reactive site
for the crosslinker, there are different possible
intramolecular crosslinked peptide pairs. For example,
a protein with 10 enzymatic cleavage sites will have 66
possible complete and incomplete digest fragments; if
one fifth of these contain a crosslinker-reactive site,r Inc. Received June 27, 2003
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protein with 20 cleavage sites will have 231 possible
digest peptides and 1035 possible crosslinked pairs. The
number of possible crosslinked peptides is thus fairly
large, and grows rapidly with the number of cleavage
sites. Furthermore, this number would be roughly
squared for intermolecular crosslinking between two
proteins. While not all these crosslinked peptides will
be observed due to the chemical and geometric selec-
tivity of the crosslinking reaction, they must all none-
theless be considered in interpreting experimentally
observed m/z values, as must surface-labeling products
and non-crosslinked peptides. Accordingly, several
computer programs have been described to aid in the
analysis of mass spectra obtained from crosslinked,
digested proteins [3, 5, 10, 11].
Several methods have been described for distin-
guishing crosslinked peptide species in mass spectra of
crosslinked and digested proteins. Some of these meth-
ods use isotopically-labeled crosslinkers [12, 13] or
proteins [14] that yield a distinctive signature in the
mass spectrum. Chemical [15, 16] or isotopic [17] meth-
ods for post-digestion labeling the termini of peptides
provide another type of mass spectrometric signature
for differentiating and separating crosslinked peptide
pairs from non-crosslinked or single-end crosslink de-
rivatized peptide species. A chemical or isotopic label
on a peptide or protein offers the possibility of distin-
guishing “single-ended” crosslinks from full crosslinks,
while labels on the crosslinking reagents themselves do
not. Crosslinking reagents that fragment under colli-
sion-induced dissociation conditions to yield a charac-
teristic low-mass marker ion allow identification of
peptides containing crosslinks [18, 19]. Although not
related to mass spectrometric detection, a fluorescent
tag on the crosslinker allows identification of
crosslinked proteins in gel separations [20].
These techniques rely on the observation of a char-
acteristic pattern in the mass spectrum or tandem mass
spectrum of the analyte mixture. However, if the signal-
to-noise ratio of the crosslinked species yielding this
pattern is insufficient, the pattern cannot be reliably
discerned. The presence of “uninformative” peptides
(vide supra), combined with low concentrations of
crosslinked species, can thus thwart the measurement.
Therefore, a separation method for enriching the ana-
lyte mixture in the crosslinked species would be useful
for reducing levels of non-crosslinked peptides while
simultaneously increasing the concentration of
crosslinked species in the analyte mixture. An affinity
separation provides such an advantage, as demon-
strated by Trester-Zedlitz et al. [21]. The biotin–avidin
interaction is a logical choice for this affinity separation;
a biotin-labeled crosslinker can be extracted, along with
its attached peptide(s), from a complex peptide mixture
using an immobilized avidin separation medium. The
relatively small size of the biotin moiety does not
greatly increase the mass of a crosslinker, thereby
minimizing both steric hindrance problems in thecrosslinking reaction, and negative effects on the mass
spectrometric measurement. The high affinity of biotin
for avidin should improve the selectivity of the mea-
surement.
In this paper, we describe a model system for sepa-
rating biotinylated, crosslinked peptides from tryptic
digests of crosslinked proteins. This system is based on
the reaction between the peptide neurotensin (pGlu-
Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu) and
a commercially-available crosslinker, sulfo-SBED (sulfo-
succinimidyl-2-[6-{biotinamido}-2-{p-azidobenzamido}hex
anoamido]ethyl-1,3-dithiopropionate). Sulfo-SBED, cho-
sen primarily because it contains a biotin moiety, is a
heterobifunctional crosslinker, incorporating an N-hy-
droxysuccinimide (NHS) ester that is reactive toward
primary amines [22] and a photoactivatable aryl azide
group that typically inserts into N™H or C™H bonds with
accompanying loss of N2 [1, 22, 23]. A disulfide bond in
sulfo-SBED allows cleavage of the crosslink using thiol
reagents. The primary amine on the single lysine side
chain is the only position to which the NHS group of
sulfo-SBED can attach, as there is no primary amine at the
N-terminus (pyroglutamic acid). The photoactive aryla-
zide group of sulfo-SBED can presumably attach any-
where on the neurotensin, within the constraints of the
sulfo-SBED linker arm length. The expected product of the
reaction between sulfo-SBED and neurotensin was ob-
served, along with more abundant side reaction products.
Although the model system of neurotensin and sulfo-
SBED differs from a crosslinked protein in that the peptide
is much smaller than a protein, and the arylazide group
can attach non-selectively, this simple system allowed
examination of crosslinked reaction products without con-
gestion of the mass spectrum by other peptides. Finally,
we describe optimization of an avidin affinity separation
of sulfo-SBED-crosslinked neurotensin from non-biotiny-
lated peptides.
Experimental
Reagents
Sulfo-SBED and Immunopure immobilized monomeric
avidin beads were purchased from Pierce (Rockford,
IL). Organic solvents were HPLC grade. Water was
either from a Millipore (Bedford, MA) system, or HPLC
grade (Burdick and Jackson, Muskegon MI). Dithiothre-
itol (DTT), iodoacetamide, neurotensin, bovine hemo-
globin and buffer components were used as received
(Sigma, St. Louis MO). -Cyano-4-hydroxycinnamic
acid (CHCA, Aldrich, Milwaukee, WI) was recrystal-
lized from ethanol before use. Immobilon NC Pure
nitrocellulose was obtained from Millipore. Sequencing
grade modified trypsin was used as supplied by Pro-
mega (Madison, WI). Bovine serum albumin was from
ICN Biomedicals (Aurora, OH).
834 HURST ET AL. J Am Soc Mass Spectrom 2004, 15, 832–839Crosslinking
Neurotensin was dissolved at 1 mg/mL in phosphate
buffer (0.1 M phosphate, 0.18 M Na, pH 7.5). Sulfo-
SBED was weighed and dissolved in the same buffer
under subdued light immediately before use. 100 L of
the neurotensin stock was combined with 50 L of 4.4
mg/mL sulfo-SBED for results in Figures 1 and 3; 100
L of the neurotensin stock was combined with 20 L
of 5 mg/mL sulfo-SBED for results shown in Figure 2.
Neurotensin and sulfo-SBED solutions were combined
in 96-well microtiter plates and maintained under sub-
dued light with aluminum foil wrapping for 30–60 min
at room temperature to allow reaction with primary
amines. 2 L of 1 M Tris (pH 8) was added to each
reaction to hydrolyze unreacted NHS groups. A 365 nm
UV lamp (Rad-Free Model RF UV-365, Schleicher and
Schuell, Keene, NH, equipped with an 8 W bulb, model
BLE760B, Spectronics, Westbury NY), held 5 cm dis-
tant from sample solutions, was used to activate the
arylazide portion of the crosslinker. Samples were re-
duced by adding DTT to a final concentration of 50 mM
and incubating for 1 h at room temperature. Following
reduction, selected samples were derivatized by incu-
bation for 1 h in the dark with 50 mM iodoacetamide.
Digestion of Hemoglobin
Bovine hemoglobin was digested to provide a set of
“background” peptides. Hemoglobin was dissolved at 2
mg/mL in 50 mM Tris buffer, pH 8, and denatured by
heating for 1 h at 60 °C in 6 M guanidine HCl. The
sample was diluted with 5 volumes of 50 mM Tris
buffer (pH 8), and trypsin was added at a mass ratio of
50:1 (hemoglobin:trypsin). The sample was incubated
overnight at 37 °C. A MALDI-TOF mass spectrum ob-
tained after the digestion showed a substantial peak for
trypsin at m/z 23722, but the signal due to intact  and
 hemoglobin chains was negligible, indicating near-
complete digestion (data not shown). In order to pre-
vent subsequent tryptic degradation of avidin, peptides
were isolated from intact trypsin by passing the digest
solution through a 10,000 Da MWCO centrifugal filter
(Microcon YM-10, Millipore), retaining the flow-
through.
Affinity Chromatography
Avidin affinity capture of biotinylated species was
performed using immobilized monomeric avidin. Small
batches (typically 100 L) of beads in 50% aqueous
suspension were prepared for use by washing with 400
L of 0.1 M phosphate buffer (pH 7.5, 0.18M Na), and
collecting the beads by centrifuging at 2000 g for 3 min.
The beads were washed with 400 L 0.1M glycine (pH
2.8), collected, and washed again with 400 L phos-
phate buffer. The beads were then incubated with
end-over-end rotation for 30 min in 2 mM biotin in
phosphate buffer, collected, and incubated for 30 min in
1.5 M bovine serum albumin in phosphate buffer. Thebeads were washed and collected successively from 400
uL 0.1 M glycine buffer, 400 L 10 or 20% methanol in
50 mM NH4HCO3, and 400 L phosphate buffer.
50 L of a 1:100 dilution of the crosslinking reaction
originally containing 250 nmol sulfo-SBED and 60 nmol
neurotensin was combined with 50 L of the purified
tryptic digest of hemoglobin. This mixture was com-
bined with 20 L of a 50% slurry of prepared avidin
resin in an 0.2 mL tube, and incubated for 3 h at room
temperature with end-over-end rotation. The beads
were collected, washed one to three times with 100 L
phosphate buffer, and once with 10 or 20% methanol in
50 mM NH4HCO3. Biotinylated species were eluted
from the beads using several 10-L portions, or one
100-L portion, of 50% acetonitrile in aqueous 0.4%
trifluoroacetic acid. Acetonitrile was removed via two
rounds of adding one volume of water and reducing by
approximately half the volume of the eluate using a
Speedvac AES1000 centrifugal vacuum concentrator
(Savant, Holbrook, NY). The resulting aqueous eluate
was prepared for MALDI analysis by purification using
a C18 ZipTip (Millipore); ZipTip purification was also
performed prior to MALDI on aliquots of the original
sample solution, and on supernatants from intermedi-
ate wash steps in the avidin separation.
Mass Spectrometry
Matrix-assisted laser desorption/ionization (MALDI)
mass spectra were obtained using a PerSeptive Biosys-
tems Voyager Elite DE time-of-flight mass spectrometer
equipped with a nitrogen laser (Applied Biosystems,
Framingham, MA). Spectra were obtained in reflector
mode, with 20 kV total accelerating voltage, 15 kV
applied to the grid, 1 kV applied to the guide wire,
and a 140 ns acceleration delay. Spectra are averages of
up to 256 individual laser pulses, obtained from several
locations on each sample spot. Sample aliquots were
applied to a pre-spotted thin-layer matrix, prepared by
drying 0.5 L portions of 5 g/L nitrocellulose, 20 g/L
-cyano-4-hydroxycinnamic acid in 1:1 isopropanol:
acetone to the sample plate [24]. Internal calibration of
the m/z axis was performed using known peptide
species.
Results and Discussion
Identification of Reaction Products
Scheme 1 shows a number of the possible products of
the reaction between sulfo-SBED and neurotensin, in-
cluding a “full” intramolecular crosslink (first column),
attachment of only the arylazide photoreactive group to
neurotensin (second column), and single-ended reac-
tion of NHS with the neurotensin lysine (third column).
Oxidized analogs of sulfur-containing products in
Scheme 1 are indicated by an “ox” subscript. Scheme 1
also shows products of subsequent reactions with di-
thiothreitol (DTT) and iodoacetamide, which were per-
formed to verify the structures of the crosslinked neu-
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spectra of (1a) products of the reaction of sulfo-SBED
with neurotensin, (1b) DTT reduction of this reaction
mixture, and (1c) iodoacetamide derivatization of the
reduced species shown in (1b). Structures from Scheme
1 that are consistent with observed peaks are indicated
in Figure 1. Most features in these spectra can be
assigned as unreacted neurotensin, or as complete or
incomplete intramolecular crosslinking of neurotensin
by sulfo-SBED. Unreacted neurotensin (calculated mo-
noisotopic [M  H]  1672.92) is visible in Figure 1a
and b, but was not detected when the amount of
sulfo-SBED was doubled (data not shown).
The two most abundant peaks in Figure 1a corre-
spond to products predicted in Scheme 1, indicating
that the NHS and arylazide reactions proceeded effi-
ciently. The intense peak at m/z 2323.1 in Figure 1a
corresponds to Iox, II, or IIIox, or some combination of
these species. On DTT reduction, Iox would yield IVox,
for which a peak is observed at m/z 2325.1 in Figure 1b.
Treatment with iodoacetamide yielded peaks at m/z
2382.2 and 2439.2 in Figure 1c. These two peaks corre-
spond to addition of one and two carbamidomethyl
groups (C2H3NO; 57 Da), respectively, to IVox, which
contains two free sulfhydryl groups, to form VII1,ox and
VII2,ox. II would yield V on reduction; no correspond-
ing peak occurs in Figure 1b. IIIox on reduction would
yield VI, which is the most abundant peak in Figure 1b.
The corresponding iodoacetamide derivative, IX, is the
most abundant peak in Figure 1c. The species observed
at m/z 2341.2 in Figure 1a is consistent with IIox;
reduction with DTT would yield Vox, for which a peak
at m/z 2237.1 is observed in Figure 1b, although no
of reaction of 250 nmol sulfo-SBED and 60 nmol
T, and (c) reaction of free sulfhydryls with
ed under subdued light for 45 min, while the
for 90 min with 365 nm irradiation.Scheme 1. Reaction of sulfo-SBED with neurotensin (NT). B 
biotin; NHS  N-hydroxysuccinimide, DTT  dithiothreitol, IAM
 iodoacetamide. The “ox” subscript indicates addition of an
O-atom to a species. Bold numbers represent structures consistent
with observed peaks in Figure 1. Monoisotopic, neutral masses are
listed in parentheses for each structure.Figure 1. MALDI-TOF mass spectra of (a) products
neurotensin, (b) reduction of the product by DT
iodoacetamide. The amine-NHS reaction was perform
photoactivated reaction was subsequently performed
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Figure 1c. In addition to the two major peaks observed
in Figure 1a, a faint signal above background at m/z
2307.1 can be assigned either as I or III, since these
species differ in mass by only 1 Da, and the observed
distribution of peaks spaced by 1 Da is wider than the
predicted 12C and 13C isotope pattern for a single
species of this size (see insets in Figure 1). On reduction
by DTT, I would be converted to IV, which is 2 Da
heavier. However, IV is not observed in Figure 1b,
which is not surprising given the low S/N for the I/III
peak in Figure 1a. III would be reduced to VI, which,
although observed as an intense peak in Figure 1b,
probably originates mainly from the more abundant
IIIox (vide supra). The m/z 2444.1 peak in Figure 1a is
not assigned.
Figure 2 shows mass spectra resulting from shorter
UV irradiation times. Peaks corresponding to unreacted
neurotensin, the expected crosslinking product I, its
oxidized counterpart Iox, and “single-ended” sulfo-
SBED addition (II, IIox, III and IIIox) are seen in Figure
2a, for which UV irradiation time was 15 min. (Note in
Figure 2 that a peptide near m/z 1543 was present as a
contaminant, and exhibits reaction products similar to
those observed for neurotensin with corresponding
peaks marked in the figure by asterisks.) Reduction of
this product with DTT yielded the spectrum shown in
Figure 2b. The peaks in Figure 2b at m/z 2309.1 and
2325.1, shifted by 2 Da from I and Iox in Figure 2a,
appear to be fully-crosslinked products; see the insets to
Figure 2a and b. The mass spectrum resulting from the
“zero” time UV exposure is shown in Figure 2c. Peaks
Figure 2. MALDI-TOF mass spectra of produc
neurotensin (a) 15 min UV irradiation, (b) reduc
0 min UV irradiation, (d) reduction of the 0 min
an asterisk are due to an impurity in the neurot
of this impurity.consistent with I or III (m/z 2307.9), Iox, II, or IIIox (m/z
2325.0) and an unassigned peak at m/z 2335.1, also
observed after UV exposures of 90 min (Figure 1a) or 15
min (Figure 2a), are observed. However, on reduction
with DTT, Figure 2d shows that all these peaks from the
“zero” UV exposure shift by 2 Da, suggesting that
they were products III and IIIox resulting from single-
ended reaction of the NHS moiety of the crosslinker.
The remaining peaks at m/z 2309.1 and 2325.1 in Figure
2b that both depend on the presence of UV, and shift by
2 Da on DTT reduction, are thus likely to be authentic
fully-crosslinked products. The 15 min UV exposure
appears to decrease the degree of oxidation, as evi-
denced by the increase of intensity at m/z 2309.1 versus
2325.1 in Figure 2b compared to Figure 1b.
The data in Figures 1 and 2 show the occurrence of at
least two side reactions to the desired crosslinking. A
“single-ended” reaction, in which only the amine-reac-
tive moiety of sulfo-SBED attaches to the lysine side
chain of neurotensin, apparently leads to the predomi-
nant product III (or IIIox). On reduction, this product
yields VI at m/z 1760.9, which is the most abundant
peak in spectra obtained for 0, 15, and 90 min UV
exposures, as shown in Figure 2d, b, and 1b, respec-
tively. The arylazide portion of the crosslinker does not
attach to the neurotensin in this side reaction. As the
“IV/VI ratio” column of Table 1 shows, varying the
time of UV exposure from 15 to 90 min did not appear
to increase the yield of the fully-crosslinked product in
the photoreaction step, suggesting that the photoreac-
tion proceeds rapidly to produce either the desired
fully-crosslinked product or a side reaction product
reaction of 114 nmol sulfo-SBED and 60 nmol
f the 15 min UV reaction product with DTT, (c)
reaction product with DTT. Peaks marked with
sample with m/z 1543.9, and reaction productsts of
tion o
UV
ensin
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does not create a bond to the peptide will, on reduction,
yield Structure VI. The second major side reaction,
oxidation, appears to occur with a yield equal to or
greater than the fully crosslinked product. The extent of
oxidation appears to be increased by increasing the
duration of UV exposure, as shown in the “IV/IVox”
column of Table 1. Peaks in Figures 1 and 2 correspond-
ing to species such as I, II, III, IV, V, and VII that
incorporate the portion of the crosslinker containing the
biotin and arylazide moieties exhibit 16 Da satellites,
suggesting that this part of the sulfo-SBED molecule is
the site of oxidation. The site of oxidation does not
appear to be on the neurotensin peptide itself. The fact
that satellite peaks at 16 Da are not observed for the
m/z 1760 peak (VI), which contains a potentially oxidiz-
able –SH group, supports the assignment of the m/z
2323.1 and 2341.2 peaks in Figure 1a either as incorpo-
ration of a 16 Da species during the attachment of the
Figure 3. Avidin affinity purification of sul
hemoglobin tryptic digest peptides. Sample was
0.3 M in each hemoglobin peptide. (a) Befo
avidin resin, (c) supernatant from phosphate
methanol in 50 mM ammonium bicarbonate, (e
hemoglobin digest peptides are labeled with th
unreacted neurotensin is marked NT.
Table 1. Peak area ratios for DTT-treated crosslinking and side
reaction products
UV exposure
time (min.) IV/VI ratioa IV/IVox ratio
a Figure
0 0.013 Not observed 2d
15 0.050 0.79 2b
90 0.048 0.24 1b
aPeaks integrated over 5 (VI) or 7 (IV, IVox) Da range around monoiso-
topic peak.arylazide to neurotensin [25], or as oxidation of the
biotin sulfur, rather than oxidation of the sulfur atoms
involved in the disulfide linkage. Supporting this as-
signment is the fact that oxidation at a methionine
sulfur is often seen in mass spectra of peptides; the
oxidized sulfur is part of a thioether moiety in both the
biotin group of sulfo-SBED and in the side chain of
methionine. Careful degassing of solutions and other
experimental refinements could decrease the extent of
this oxidation, leading to simpler spectral interpretation
and a decreased splitting of the analytical signal among
multiple peaks. Other refinements to the crosslinking
also should be explored. For instance, despite remain-
ing unreacted neurotensin, a whitish to yellowish pre-
cipitate was observed in some reactions, suggesting
precipitation of sulfo-SBED, or perhaps excessive
crosslinking leading to multimers. It might be possible
to distinguish between these two possibilities by includ-
ing solvents such as DMSO, in which sulfo-SBED is
more soluble, in the reaction mixture.
Avidin Capture of Crosslinked Peptides
To determine whether peptide species containing an
affinity-labeled crosslink, such as that introduced by
reaction with sulfo-SBED, could be purified from a
background of non-labeled peptides, an affinity capture
experiment was performed using a mixture of sulfo-
SBED-derivatized neurotensin and a tryptic digest of
bovine hemoglobin. The affinity capture matrix was
ED crosslinked neurotensin from mixture of
100 L volume at 2 M total neurotensin and
paration, (b) supernatant after incubation with
r wash, (d) supernatant from wash with 20%
ent from avidin beads. Peaks corresponding to
ino acid residue numbers in the  or  chain;fo-SB
in a
re se
buffe
) elu
e am
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the samples over a 3 h time period with gentle mixing
to maximize capture of biotinylated species while min-
imizing the surface area on which loss of sample could
occur. Figure 3 shows MALDI-TOF mass spectra ob-
tained at various stages of the avidin separation. The
spectrum in Figure 3a shows a number of peaks assign-
able as tryptic peptides from hemoglobin, underivat-
ized neurotensin at m/z 1672.9, and weak signals corre-
sponding to sulfo-SBED-derivatized neurotensin at m/z
2324.2 (Iox, IIox, or III) and m/z 2341.3 (IIox). After
incubation with avidin beads, only underivatized neu-
rotensin and hemoglobin digest peaks were observed in
the supernatant (Figure 3b). A wash of the avidin beads
with phosphate buffer yielded a spectrum, Figure 3c,
that showed only hemoglobin digest peaks. A subse-
quent wash with 20% methanol in 50 mM aqueous
ammonium bicarbonate [26] showed (Figure 3d) con-
tinuing elution of hemoglobin digest peptides, but also
some sulfo-SBED-derivatized neurotensin at m/z 2325.0
and 2342.9. Finally, Figure 3e shows the MALDI spec-
trum of the solution used to elute biotinylated species
from the beads, 50% acetonitrile in aqueous 0.4% triflu-
oroacetic acid; this spectrum contains predominantly
the sulfo-SBED-derivatized neurotensin peaks observed
weakly in the pre-avidin mixture, Figure 3a, plus a
small peak at m/z 1760.9 corresponding to cleavage of
the disulfide bond of the sulfo-SBED, a phenomenon
previously reported under MALDI conditions [27].
These results suggest that the batch avidin bead sepa-
ration enriches the biotin-containing peptide species
fairly efficiently, with little non-specific binding. A
semi-quantitative estimate of the enrichment of biotin-
ylated species in this procedure can be obtained from
ratios of peak areas in Figure 3a and e. The ratio of the
areas of the m/z 2322 peak to the m/z 1274 hemoglobin
digest peak (30–39) is 1.2 in Figure 3a, and increases to
11 in Figure 3e. Note that the very weak m/z 1274 peak
is the only hemoglobin digest peak observed in Figure
3e after the affinity isolation, so this estimate of the
enrichment is probably a lower limit.
The results shown in Figure 3 are encouraging, even
though the relative amounts of the various components
of the mixture may not reflect those that would be
encountered in a protein crosslinking experiment. As-
suming complete and uniform recovery in the purifica-
tion of the hemoglobin tryptic peptides, the 100 L
solution undergoing affinity capture was 0.3 M in
each hemoglobin peptide, for a total of 2 g of
hemoglobin tryptic peptides. The concentration of bio-
tinylated peptides is more difficult to estimate, since the
yield of the crosslinking reaction was not easily mea-
sured. If no crosslinking had been performed, the
neurotensin concentration in the capture sample would
have been 2 M. In the crosslinking reaction from
which this avidin capture sample was derived, as
Figure 3a shows, unreacted neurotensin was detected
prior to avidin capture; 2 M is thus an upper limit for
the concentration of biotinylated sulfo-SBED derivat-ized neurotensin. A 1 M concentration would corre-
spond to 230 ng of sulfo-SBED derivatized neuroten-
sin, or about one ninth the mass of hemoglobin tryptic
peptides estimated to be in the sample. In experiments
involving crosslinking of proteins or protein complexes,
this ratio would be less favorable, but the results
presented in Figure 3 nonetheless demonstrate an en-
richment of biotinylated species.
Several factors improved the overall yield and spec-
ificity of the avidin isolation. The experiments were
performed using a monomeric avidin resin, which
retains biotin less strongly than native tetrameric avidin
and therefore allows gentler elution [26]. Initial experi-
ments following a protocol similar to that provided by
the resin manufacturer, but scaled down in volume and
implemented as a batch (rather than column) method,
resulted in significant non-specific binding to the beads
(data not shown). In addition to the biotin blocking step
in the manufacturer’s protocol, a second blocking step
using bovine serum albumin further reduced non-
specific binding of non-biotinylated peptides by the
avidin beads, as did incorporation of a 20% metha-
nol/50 mM bicarbonate wash [26]. Additional washes
of the beads with phosphate buffer may also be useful
for further decreasing non-specific binding (data not
shown.) Based on the manufacturer’s stated biotin
binding capacity, the quantity of capture beads added
was sufficient to bind an amount slightly greater (1.2-
fold) than the amount of neurotensin (and therefore any
biotinylated sulfo-SBED derivative of neurotensin) in
the sample. Adjusting the amount of beads would be
guided by maximizing capture of biotinylated species
while minimizing non-specific capture.
Conclusions
The ability to isolate crosslinked peptides from non-
crosslinked peptides would greatly facilitate the use of
mass spectrometry for locating chemical crosslinks in-
troduced into proteins and protein complexes. Sulfo-
SBED produces several products in addition to the
simple predicted intramolecular crosslink of neuroten-
sin. Knowledge of the identities of these products
gained from the simple model system described here
will be helpful in interpreting mass spectrometry data
from crosslinking experiments on larger proteins or
protein complexes, which will contain multiple
crosslinking sites. Other biotinylated crosslinkers could
be synthesized to accommodate a wider variety of
proteins and protein complexes. A biotinylated homo-
bifunctional crosslinker with two NHS groups, both
reactive toward primary amines on proteins [21], is one
such possibility; such a reagent would reduce the
non-specificity introduced by the arylazide group of
sulfo-SBED. Preliminary evidence suggests that tandem
mass spectrometry experiments, such as MS-MS or MS3,
can identify the two peptides in a crosslinked pair [5, 10,
28]. Extension of well-established techniques, such as
cross-correlation-based algorithms for matching tan-
839J Am Soc Mass Spectrom 2004, 15, 832–839 MS OF AFFINITY PURIFIED CROSSLINKED PEPTIDESdem MS data of peptides to protein databases [29], or de
novo sequence determination methods [30], could
prove feasible for analysis of crosslinked peptide pairs.
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